These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30504712)

  • 21. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Thromb Haemost; 2018 Feb; 118(2):279-287. PubMed ID: 29443369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated with a Large Decline in Renal Function or Progression to Renal Insufficiency in Hospitalized Atrial Fibrillation Patients with Early-Stage CKD.
    Hu L; Xiong Q; Chen Z; Fu L; Hu J; Chen Q; Tu W; Xu C; Xu G; Li J; Hong K
    Int Heart J; 2020 Mar; 61(2):239-248. PubMed ID: 32173696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.
    Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GYH;
    Clin Res Cardiol; 2017 Jun; 106(6):420-427. PubMed ID: 28078448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.
    Zheng JY; Cao Y; Li DT; Qiu YG; Zhao L; Xu ZM; Huang YX; Hong ZB; Li TC; Tang YD; Guo CJ; Ma ZM; Wu YQ; Chen Y
    Acta Cardiol; 2022 Jun; 77(4):360-365. PubMed ID: 34353224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GYH
    Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Chronic Kidney Disease on Utilization of Coronary Angiography and Percutaneous Coronary Intervention, and Their Outcomes in Patients With Non-ST Elevation Myocardial Infarction.
    Murray J; Balmuri A; Saurav A; Smer A; Alla VM
    Am J Cardiol; 2018 Dec; 122(11):1830-1836. PubMed ID: 30336930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT-AF II.
    Yao RJR; Holmes DN; Andrade JG; Levin A; Piccini JP; Fordyce CB
    J Am Heart Assoc; 2023 Mar; 12(6):e026605. PubMed ID: 36892077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of moderate chronic kidney disease with insufficient improvement of fractional flow reserve after stent implantation.
    Sakoda K; Tanaka N; Hokama Y; Hoshino K; Murata N; Yamashita J; Yamashina A
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):E38-44. PubMed ID: 26489880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal trends in prevalence and outcomes of atrial fibrillation in patients undergoing percutaneous coronary intervention.
    Morita Y; Hamaguchi T; Yamaji Y; Hayashi H; Nakane E; Haruna Y; Haruna T; Hanyu M; Inoko M
    Clin Cardiol; 2020 Jan; 43(1):33-42. PubMed ID: 31696533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment.
    Lima EG; Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Favarato D; Hueb AC; Rahmi Garcia RM; Franchini Ramires JA; Filho RK
    Ann Thorac Surg; 2016 May; 101(5):1735-44. PubMed ID: 26794894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of chronic kidney disease on long-term outcomes following semi-urgent and elective percutaneous coronary intervention.
    Soh RY; Sia CH; Lau RH; Ho PY; Timothy NY; Ho JS; Kaur H; Sim HW; Yeo TC; Tan HC; Chan MY; Loh JP
    Coron Artery Dis; 2021 Sep; 32(6):517-525. PubMed ID: 33229937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
    Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
    Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R
    Fu S; Zhou S; Luo L; Ye P
    Clin Interv Aging; 2017; 12():1233-1238. PubMed ID: 28848331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.